Omicron Now Has Three Sub-Variants, Say Experts

HYDERABAD : The variant of concern, Omicron, has now three siblings – one up from two sub-lineages discovered last week.

According to Phylogenetic Assignment of Named Global Outbreak Lineages (PANGOLIN) that assigns lineages under ‘Pango lineage’ system to various viruses including the novel coronavirus that causes Covid-19, the third outlier of Omicron was found from a sample collected from England on December 3. The new outlier of Omicron variant is temporarily named England/MILK-2D24AC9/2021.

Dr Vinod Scaria of Institute of Genomics and Integrative Biology (IGIB), New Delhi, confirmed the development by tweeting late on Sunday about the new outlier of Omicron lineage with some shared mutations.

Omicron variant or B.1.1.529 split into two sub-lineages BA.1 and BA.2 earlier this month. These two variants have some shared mutations, besides some mutations that are unique to them. “A new diverse genome has appeared within the B.1.1.529 lineage that has all of the shared mutations of B.1.1.529, some of the mutations unique to BA.1 and some unique to BA.2 plus a few of its own,” PANGOLIN announced in its website.

It added it seems likely the new Omicron outlier is an additional circulating member of B.1.1.529 diversity and recombination has occurred in its history. It also said it “may have mutated prior to emergence of BA.1 clade based on pattern of mutations.” It said, “as a single genome it doesn’t yet require a lineage designation and at the moment it will be classified as a member of Omicron”. Experts say though Omicron has been spreading faster than previous variants, most cases are mild.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India